Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article about a $948 million patent infringement verdict between Intel and VLSI Technology LLC;
- another article about a Federal Circuit decision finding a generic cancer drug infringes on “Abbvie’s Pharmacyclics and Johnson & Johnson’s Janssen Biotech . . . blockbuster cancer drug Imbruvica”; and
- a blog post about a Federal Circuit decision affirming the Patent Trial and Appeal Board’s decision “involving American National Manufacturing and Sleep Number Corp.”